Perjeta Treatment of HER2 positive Breast Cancer

09:42 EDT 5 Jun 2019 | Cancer Connect

FDA Approves Perjecta for Adjuvant Treatment of HER2-positive Breast Cancer

Original Article: Perjeta Treatment of HER2 positive Breast Cancer


More From BioPortfolio on "Perjeta Treatment of HER2 positive Breast Cancer"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...